Please login to the form below
patient enrolment
This page shows the latest patient enrolment news and features for those working in and with pharma, biotech and healthcare.
Entering the era of digital trials
At the same time, the data explosion and emergence of automated analytical tools have raised expectations that the industry can crack the patient enrolment conundrum and other persistent problems. ... It is at this stage in the process that smartphone
Latest news
-
Viking throws down gauntlet in NASH battle
The caveat of course is that the two trials have different enrolment criteria and patient baseline characteristics – in fact Madrigal’s trial was much bigger with around 150 patients versus
-
Merck suspends two Keytruda trials after patient deaths
Investigators to look at Keytruda with Pomalyst and Revlimid. Merck &Co has paused patient enrolment in two trials of Keytruda to allow investigators to explore reports of deaths among patients taking
-
Trials of AZ's durvalumab restart as FDA hold is relaxed
Patient recruitment can restart in two trials of AstraZeneca's PD-L1 inhibitor durvalumab placed under temporary suspension by the FDA, says the company. ... The phase III KESTREL trial has already re-opened for new patient enrolment at some clinical
-
Clinical trials enter the genomic age
Every day, a gigantic amount of genomic information is generated and analysed to identify pathogenic mutations in patient DNA. ... However, the production and analysis of patient genomic profiles is only the first part of the Data-Driven Medicine story.
-
FDA panel says no to quick approval of Clovis' rociletinib
Patient enrolment for the trial is expected to complete in late 2018.
More from news
Approximately 1 fully matching, plus 31 partially matching documents found.
Latest Intelligence
-
Streamlining clinical trials – why better data use is key
Investment in patient enrolment and fulfilling compliance requirements are likely to remain staples of clinical drug trials – and for good reason. ... endpoints and patient safety, which can lead to better data, faster enrolment and reduced patient
-
The trials and tribulations of rare opportunities
Patient eligibility criteria can also impact patient enrolment. “When studying potential disease-modifying therapies, there is often a desire from study sponsors to enroll patients in the early stages of the ... Patient-centricity is also core to
-
Making digital health personal
The reasons for non-adherence among patients entering the programme were captured at enrolment via a patient survey (eg concerns about potential side effects, difficulties with routines). ... However, it is possible to carefully navigate the regulatory
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
How to break down the barriers to patient enrolment
In the final instalment, we look at one the biggest hurdles to successful patient support programme s: patient enrolment. ... of the patient support programme, and explain how to easily enrol their patients.Our top tips on activating the sales force
-
Enablers of drug innovation could lie in the numbers
trials industry estimates that 80% of clinical trials are delayed by at least one month because of unfulfilled enrolment numbers, and that patient recruitment delays account for, on average, 4.6 ... help position research centres so as to increase the
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Biogen delays filing of Alzheimer’s drug, which hits its share price
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Merck’s Keytruda hits the mark in triple negative breast cancer
- Amgen adds Otezla to the COVID-19 candidate list
- Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir
- Moderna to begin pivotal phase 3 trial of COVID-19 vaccine in July
- Impetus Digital Fireside Chat with Susanne Somerville of Chronicled
- Impetus Digital Fireside Chat with Bechara Saab of Mobio Interactive
- FDA delays review of Novartis’ MS drug ofatumumab
- Sanofi makes ‘best-in-class’ claim for Sarclisa in myeloma
- Q&A: Kay Wesley
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- Working together against COVID-19
- Analysing social media conversations to see what HCPs are saying online about the global pandemic...
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....
Quick links
Infographics
